Polymorphisms and haplotypes in the TP53 and WRAP53 genes may affect their products, thereby causing cancer vulnerability, tumor invasiveness and prognosis, or cancer therapy response [20,29,30]. The gene discussed is WRAP53; the disease is neoplasm.